Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Genital Neoplasms, Female × Palonosetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 33 Nausea 22 Neoplasms 11 Breast Neoplasms 6 Lymphoma 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Multiple Myeloma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms, Male 2 Weight Loss 1 Solid Tumors 1 Sarcoma 1 Radiation Injuries 1 Pancreatic Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Nausea With Vomiting Chemotherapy-Induced 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia 1 Inflammatory Breast Neoplasms 1 Hematologic Neoplasms 1 Glioma 1 Genital Neoplasms, Female 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1

Interventions

pembrolizumab 3 Educational Status 3 anlotinib 2 Therapeutic Touch 2 Surveys and Questionnaires 2 Standard of Care 2 Radiotherapy 2 Palliative Care 2 Paclitaxel 2 Nivolumab 2 Methods 2 Interviews as Topic 2 Gemcitabine 2 Early Intervention, Educational 2 Carboplatin 2 temsirolimus 1 rucaparib 1 relacorilant 1 olaparib 1 niraparib 1 nilotinib 1 liposomal doxorubicin 1 lenvatinib 1 fosaprepitant 1 atezolizumab 1 argatroban 1 Watchful Waiting 1 Transurethral Resection of Prostate 1 Topotecan 1 Thrombopoietin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01074697 2015-04-24

GAND-emesis

Odense University Hospital

Phase 3 Completed

Genital Neoplasms, Female, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡